Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-786-4 | CAS number: 869-24-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1990
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 2-chloroethyldiethylammonium chloride
- EC Number:
- 212-786-4
- EC Name:
- 2-chloroethyldiethylammonium chloride
- Cas Number:
- 869-24-9
- Molecular formula:
- C6H14ClN.ClH
- IUPAC Name:
- 2-chloroethyldiethylammonium chloride
- Details on test material:
- - Name of test material (as cited in study report): P5524
- Substance type: Powder
- Physical state: white powder
- Analytical purity: 102%
- Purity test date: 4. 1. 1990
- Lot/batch No.: 861201
- Storage condition of test material: room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Bantin & Kingman ltd., Grimston, Aldborough, Hull, U.K.
- Age at study initiation: five to eight weeks
- Weight at study initiation: males weighed 120 - 144g, and the females 126 - 159g
- Fasting period before study: overnight fast immediately before dosing and for approximately two hours after dosing
- Housing: The animals were housed in groups of up to five by sex in solid-floor polypropylene cages with sawdust bedding.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 16 - 24°C, On one occasion the temperature was below the lower limit specified in the protocol (19°C)
- Humidity (%): 40 - 56%
- Air changes (per hr): approximately 15 changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours darkness
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 1, 2, and 4 g/L
- Amount of vehicle (if gavage): 10 mL/kg
- Justification for choice of vehicle: water soluble
- Purity: distilled water
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg with 4 g/L
DOSAGE PREPARATION (if unusual): For the purpose of this study the test material was freshly prepared, as required, at the appropriate concentration as a solution in distilled water. - Doses:
- main study: 10, 20 and 40 mg/kg bw
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: day of treatment (day 0), days 7 and 14, or at death
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, necropsy - Statistics:
- Using the mortality data obtained the acute oral median lethal dose (LD50) and 95% confidence limits of the test material were calculated using the
method of Thompson W.R., Bact. Reviews, 11, 115-145 (1947). The LD50 and 95% confidence limits were calculated for males and females separately.
Clinical observations, bodyweight and necropsy data were examined for any adverse effects resulting from treatment.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 24 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 19 - <= 32
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 24 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 14 - 39
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 25 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 19 - 32
- Clinical signs:
- other: All animals treated with 10 mg/kg appeared normal throughout the study. Common signs of toxicity noted in dose groups 20 and 40 mg/kg were hunched posture, lethargy, pilo-erection, ptosis, ataxia and loss of righting reflex. Additional signs of toxicity
- Gross pathology:
- Abnormalities noted at necropsy of animals that died or were killed in extremis during the study were haemorrhagic or abnormally red lungs,
dark liver, dark kidneys, haemorrhage of the glandular gastric epithelium and haemorrhage of the small and large intestines. The male treated with 20 mg/kg that was killed in extremis also showed an enlarged and blood filled bladder at necropsy.
No abnormalities were noted at necropsy of animals killed at the end of the study.
Applicant's summary and conclusion
- Executive summary:
The acute oral toxicity test (Coles 1990) was performed according to OECD 401 and EEC method B.1. The test material has a purity of 102%. Five males and five female rat (Sprague-Dawley) were used per test group. The initial body weight ranged from 120 - 144g (males) and 126 - 159g (females) after overnight fasting. The administration was performed by gavage. Three groups, each of ten fasted animals (five males and five females), were given a single oral dose of test material preparation at dose levels of 10, 20 and 40 mg/kg bodyweight. Deaths were noted one, two and five days after dosing. One male treated with 20 mg/kg was killed in extremis on day two. Common signs of toxicity noted in the 20 and 40 mg/kg dose groups were hunched posture, piloerection, lethargy, ptosis, ataxia and loss of righting reflex. Additional signs of toxicity noted in the 40 mg/kg dose group were decreased respiratory rate, body tremors, red/brown stains around the snout, dehydration and pallor of the extremities. Surviving animals appeared normal four days after dosing. Surviving animals showed expected gain in bodyweight during the study. Abnormalities noted at necropsy of animals that died or were killed in extremis during the study were haemorrhagic or abnormally red lungs, dark liver, dark kidneys, haemorrhage of the glandular gastric epithelium and haemorrhage of the small and large intestines. The male treated with 20 mg/kg that was killed in extremis also showed an enlarged and blood filled bladder at necropsy. No abnormalities were noted at necropsy of animals killed at the end of the study.
The LD50 (males and females) was 24 mg/kg bw, the LD50 (males) was 24 mg/kg bw and the LD50 (females) was 25 mg/kg bw.
This study was performed according to international guidelines and under GLP and fulfilled the validity criteria. Therefore, this study was considered to be Klimisch 1 study.
The obtained results are considered as relevant for the risk assessment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)